Georgia Salanti researcher
Salanti, Georgia 1976-
VIAF ID: 13249870 (Personal)
Permalink: http://viaf.org/viaf/13249870
Preferred Forms
- 100 0 _ ‡a Georgia Salanti ‡c researcher
- 100 1 _ ‡a Salanti, Georgia ‡d 1976-
- 100 1 _ ‡a Salanti, Georgia ‡d 1976-
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
Answering complex hierarchy questions in network meta-analysis | |
Erythropoiesis stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis | |
Estimating the contribution of studies in network meta-analysis: paths, flows and streams | |
Estimating the sample size of sham-controlled randomized controlled trials using existing evidence | |
Estimation of the general threshold limit values for dust | |
Evaluating the impact of imputations for missing participant outcome data in a network meta-analysis | |
Family-based versus unrelated case-control designs for genetic associations | |
A fully Bayesian application of the Copas selection model for publication bias extended to network meta-analysis | |
Homocysteine lowering interventions for preventing cardiovascular events | |
Homophily and co-occurrence patterns shape randomized trials agendas: illustration in antifungal agents | |
How to assess publication bias: funnel plot, trim-and-fill method and selection models. | |
How to interpret meta-analysis models: fixed effect and random effects meta-analyses. | |
Human recombinant activated protein C for severe sepsis | |
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis | |
The impact of trial characteristics on premature discontinuation of antipsychotics in schizophrenia | |
Impact of Violations and Deviations in Hardy-Weinberg Equilibrium on Postulated Gene-Disease Associations | |
Imputation of response rates from means and standard deviations in schizophrenia. | |
Indirect Treatment Comparison/Network Meta-Analysis Study Questionnaire to Assess Relevance and Credibility to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report | |
Industry sponsorship and selection of comparators in randomized clinical trials | |
Infant sleeping position and the sudden infant death syndrome: systematic review of observational studies and historical review of recommendations from 1940 to 2002. | |
Initial orthodontic alignment effectiveness with self-ligating and conventional appliances: a network meta-analysis in practice. | |
Is placebo response in antidepressant trials rising or not? A reanalysis of datasets to conclude this long-lasting controversy. | |
isotonic regression framework estimating and testing under order restrictions | |
Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis | |
Living network meta-analysis compared with pairwise meta-analysis in comparative effectiveness research: empirical study. | |
Living systematic review 1: Introduction - the Why, What, When and How. | |
Making the best use of available evidence: the case of new generation antidepressants: A response to: Are all antidepressants equal? | |
Meta-analysis and The Cochrane Collaboration: 20 years of the Cochrane Statistical Methods Group | |
Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines | |
Methods to estimate the between-study variance and its uncertainty in meta-analysis | |
A model for meta-analysis of correlated binary outcomes: the case of split-body interventions | |
netmeta: an r package for network meta-analysis using frequentist methods | |
Network meta-analyses should be the highest level of evidence in treatment guidelines. | |
Obstacles and opportunities in meta-analysis of genetic association studies. | |
Open release for carpal tunnel syndrome | |
Outcomes of non-invasive diagnostic modalities for the detection of coronary artery disease: network meta-analysis of diagnostic randomised controlled trials. | |
Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis. | |
Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies. | |
Planning a future randomized clinical trial based on a network of relevant past trials. | |
Planning future studies based on the precision of network meta-analysis results | |
Prevalence of evidence of inconsistency and its association with network structural characteristics in 201 published networks of interventions | |
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations | |
Psychological interventions for positive symptoms in schizophrenia: protocol for a network meta-analysis of randomised controlled trials. | |
Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis | |
Psychosocial interventions for adults who were sexually abused as children | |
Publication bias and small-study effects magnified effectiveness of antipsychotics but their relative ranking remained invariant | |
The quality of reporting methods and results in network meta-analyses: an overview of reviews and suggestions for improvement. | |
The Quality of the Evidence According to GRADE Is Predominantly Low or Very Low in Oral Health Systematic Reviews | |
Recent meta-analyses neglect previous systematic reviews and meta-analyses about the same topic: a systematic examination | |
Reconstructing 2 x 2 contingency tables from odds ratios using the Di Pietrantonj method: difficulties, constraints and impact in meta-analysis results. | |
Reporting and handling missing outcome data in mental health: a systematic review of Cochrane systematic reviews and meta-analyses | |
Research Synthesis Methods special issue on network meta-analysis: introduction from the editors | |
A road map for efficient and reliable human genome epidemiology | |
ROB-MEN: a tool to assess risk of bias due to missing evidence in network meta-analysis | |
The role of asymptomatic SARS-CoV-2 infections: rapid living systematic review and meta-analysis | |
Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors. | |
statistical importance of a study for a network meta-analysis estimate | |
Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis | |
Synthesis of observational studies should consider credibility ceilings | |
Timing matters in hip fracture surgery: patients operated within 48 hours have better outcomes. A meta-analysis and meta-regression of over 190,000 patients | |
Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis. | |
Turning the Pump Handle: Evolving Methods for Integrating the Evidence on Gene-Disease Association | |
Underlying genetic models of inheritance in established type 2 diabetes associations | |
The use of mathematical modelling studies for evidence synthesis and guideline development: a glossary | |
Using conditional power of network meta-analysis (NMA) to inform the design of future clinical trials. | |
Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions. | |
What is a multiple treatments meta-analysis? | |
WITHDRAWN: Assessment of clinical outcomes 10–20 years after autologous chondrocyte implantation | |
Α Markov model for longitudinal studies with incomplete dichotomous outcomes |